IDEX Q3 Sales Jump 10% on Strong Demand, Acquisitions

TL;DR

**IDEX is growing sales and EPS, but watch those rising interest costs and restructuring charges eating into nine-month profits.**

AI Summary

IDEX Corporation reported a strong third quarter for 2025, with net sales increasing by 10.1% to $878.7 million from $798.2 million in Q3 2024. Net income attributable to IDEX rose by 7.3% to $127.8 million, up from $119.1 million in the prior year's quarter. Diluted earnings per common share also saw a healthy increase, reaching $1.70 compared to $1.57 in Q3 2024. For the nine months ended September 30, 2025, net sales grew to $2,558.4 million from $2,405.9 million in 2024, a 6.3% increase. However, net income attributable to IDEX for the nine-month period decreased by 7.0% to $354.9 million from $381.8 million, primarily due to higher interest expense and restructuring costs. The company completed the acquisition of Micro-LAM, Inc. on July 29, 2025, for $80.7 million in cash, expanding its Scientific Fluidics & Optics segment. Restructuring expenses significantly increased to $18.3 million for the nine months ended September 30, 2025, compared to $5.4 million in the same period of 2024. Long-term borrowings increased to $1,901.6 million from $1,859.5 million at December 31, 2024, contributing to a rise in net interest expense to $48.2 million for the nine-month period, up from $27.8 million in 2024.

Why It Matters

IDEX's robust sales growth of 10.1% in Q3 2025 demonstrates strong operational performance and effective integration of acquisitions like Micro-LAM, Inc., which enhances its competitive position in advanced optics. This growth, coupled with increased diluted EPS, signals positive momentum for investors, suggesting the company is successfully navigating macroeconomic challenges. However, the decline in nine-month net income due to higher interest expense and restructuring costs highlights potential margin pressures and ongoing strategic adjustments. For employees, continued growth and strategic acquisitions could mean job stability and new opportunities, while customers benefit from an expanded product portfolio. In the broader market, IDEX's performance reflects resilience in the industrial technology sector, potentially influencing investor sentiment towards similar diversified manufacturers.

Risk Assessment

Risk Level: medium — The risk level is medium due to increased interest expense and significant restructuring costs. Interest expense – net surged to $48.2 million for the nine months ended September 30, 2025, from $27.8 million in the prior year, indicating higher borrowing costs. Additionally, restructuring expenses and asset impairments jumped to $18.3 million for the nine-month period, up from $5.4 million in 2024, suggesting ongoing operational adjustments that could impact profitability.

Analyst Insight

Investors should monitor IDEX's ability to integrate recent acquisitions and realize synergies to offset rising interest expenses and restructuring costs. While Q3 2025 showed strong sales and EPS growth, the nine-month net income decline warrants attention; assess if these costs are one-off or indicative of sustained pressure on profitability.

Financial Highlights

debt To Equity

N/A

revenue

$2,558.4M

operating Margin

N/A

total Assets

$6,969.7M

total Debt

$1,901.6M

net Income

$354.9M

eps

$4.70

gross Margin

N/A

cash Position

$593.8M

revenue Growth

+6.3%

Revenue Breakdown

Key Numbers

• $878.7M — Net Sales (Increased 10.1% in Q3 2025 from $798.2M in Q3 2024)
• $127.8M — Net Income Attributable to IDEX (Increased 7.3% in Q3 2025 from $119.1M in Q3 2024)
• $1.70 — Diluted EPS (Increased from $1.57 in Q3 2024)
• $354.9M — Nine-Month Net Income Attributable to IDEX (Decreased 7.0% from $381.8M in 2024)
• $48.2M — Nine-Month Interest Expense – Net (Increased from $27.8M in 2024)
• $18.3M — Nine-Month Restructuring Expenses (Increased from $5.4M in 2024)
• $80.7M — Micro-LAM Acquisition Cost (Cash consideration for acquisition on July 29, 2025)
• 74,849,436 — Common Stock Outstanding (As of October 24, 2025)
• $1,901.6M — Long-term Borrowings – Net (As of September 30, 2025, up from $1,859.5M at December 31, 2024)
• $593.8M — Cash and Cash Equivalents (As of September 30, 2025, down from $620.8M at December 31, 2024)

Key Players & Entities

• IDEX CORP /DE/ (company) — registrant
• Micro-LAM, Inc. (company) — acquired business
• New York Stock Exchange (regulator) — exchange where common stock is registered
• FASB (regulator) — Financial Accounting Standards Board
• SEC (regulator) — United States Securities and Exchange Commission
• $878.7 million (dollar_amount) — net sales for Q3 2025
• $127.8 million (dollar_amount) — net income attributable to IDEX for Q3 2025
• $1.70 (dollar_amount) — diluted earnings per common share for Q3 2025
• $48.2 million (dollar_amount) — net interest expense for nine months ended September 30, 2025
• $18.3 million (dollar_amount) — restructuring expenses and asset impairments for nine months ended September 30, 2025

FAQ

Risk Factors

• Increased Interest Expense [medium — financial]: Net interest expense for the nine months ended September 30, 2025, rose to $48.2 million from $27.8 million in the prior year. This increase is attributed to higher long-term borrowings, which stood at $1,901.6 million as of September 30, 2025, up from $1,859.5 million at December 31, 2024.
• Significant Restructuring Costs [medium — operational]: Restructuring expenses surged to $18.3 million for the nine months ended September 30, 2025, a substantial increase from $5.4 million in the same period of 2024. These costs impact profitability and operational efficiency.
• Acquisition Integration Risks [medium — financial]: The company completed the acquisition of Micro-LAM, Inc. for $80.7 million. Integrating this new entity presents potential operational and financial risks, including achieving expected synergies and managing new liabilities.
• Competitive Market Landscape [medium — market]: IDEX operates in competitive markets across its segments. Maintaining market share and profitability requires continuous innovation and efficient operations against rivals.
• Fluctuations in Foreign Currency Translation [low — financial]: The company experienced a significant cumulative translation adjustment of $176.7 million for the nine months ended September 30, 2025, compared to $21.5 million in 2024. This indicates substantial foreign currency impacts on reported results.

Industry Context

IDEX Corporation operates in diverse industrial sectors, including fluidics, optics, and sealing solutions. The company faces competition from specialized manufacturers and larger conglomerates. Trends such as increased demand for precision components in automation, healthcare, and energy sectors, alongside a focus on sustainability and advanced materials, shape the competitive landscape.

Regulatory Implications

As a publicly traded company, IDEX must comply with SEC regulations, including accurate financial reporting and disclosure requirements. Changes in environmental regulations or international trade policies could also impact operations and supply chains, requiring ongoing compliance efforts.

What Investors Should Do

1. Monitor the integration of Micro-LAM, Inc. to assess its contribution to revenue and profitability in the Scientific Fluidics & Optics segment.
2. Analyze the drivers behind the significant increase in restructuring expenses and interest expense to understand their impact on future earnings.
3. Evaluate the company's ability to manage its increased debt levels and maintain healthy cash flow amidst rising interest costs.
4. Assess the impact of foreign currency fluctuations on reported earnings, given the substantial cumulative translation adjustment.

Key Dates

• 2025-07-29: Acquisition of Micro-LAM, Inc. — Expands the Scientific Fluidics & Optics segment, potentially driving future growth and diversification.
• 2025-09-30: End of Nine-Month Period — Period for which financial results show increased revenue but decreased net income due to higher expenses.
• 2025-10-24: Common Stock Outstanding Date — Provides a snapshot of the company's equity structure with 74,849,436 shares outstanding.

Glossary

Restructuring expenses and asset impairments

Costs incurred due to significant changes in business operations, such as facility closures, workforce reductions, or the write-down of asset values. (These expenses significantly increased to $18.3 million for the nine months ended September 30, 2025, impacting net income.)

Cumulative translation adjustment

An accounting adjustment made to reflect the impact of foreign currency exchange rate fluctuations on the financial statements of foreign subsidiaries when consolidated. (A large positive adjustment of $176.7 million for the nine months ended September 30, 2025, indicates significant foreign currency gains.)

Noncontrolling interest

The portion of equity in a subsidiary that is not attributable to the parent company. It represents the ownership interest of outside shareholders. (A small net loss attributable to noncontrolling interest was reported, indicating a minor impact on consolidated net income.)

Goodwill

An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. (Goodwill increased to $3,408.8 million from $3,251.7 million, likely due to the Micro-LAM acquisition.)

Intangible assets – net

Non-physical assets that have value, such as patents, trademarks, and customer lists, net of accumulated amortization. (These assets decreased slightly to $1,281.5 million from $1,284.8 million, suggesting amortization exceeding new additions.)

Year-Over-Year Comparison

Compared to the prior year, IDEX Corporation reported a 10.1% increase in net sales for Q3 2025, reaching $878.7 million. However, for the nine-month period, net income attributable to IDEX decreased by 7.0% to $354.9 million, primarily due to a significant rise in restructuring expenses (from $5.4 million to $18.3 million) and net interest expense (from $27.8 million to $48.2 million). Long-term borrowings also increased, contributing to higher debt servicing costs.

Key Financial Figures

• $0.01 — ich registered Common Stock, par value $0.01 per share IEX New York Stock Exchange

Filing Documents

• iex-20250930.htm (10-Q) — 2041KB
• iex-20250930xex311.htm (EX-31.1) — 8KB
• iex-20250930xex312.htm (EX-31.2) — 8KB
• iex-20250930xex321.htm (EX-32.1) — 4KB
• iex-20250930xex322.htm (EX-32.2) — 5KB
• 0001628280-25-047080.txt ( ) — 11055KB
• iex-20250930.xsd (EX-101.SCH) — 58KB
• iex-20250930_cal.xml (EX-101.CAL) — 89KB
• iex-20250930_def.xml (EX-101.DEF) — 357KB
• iex-20250930_lab.xml (EX-101.LAB) — 752KB
• iex-20250930_pre.xml (EX-101.PRE) — 601KB
• iex-20250930_htm.xml (XML) — 2133KB

Financial Information

Part I. Financial Information

Financial Statements

Item 1. Financial Statements 1 Condensed Consolidated Statements of Income 1 Condensed Consolidated Statements of Comprehensive Income 2 Condensed Consolidated Balance Sheets 3 Condensed Consolidated Statements of Equity 4 Condensed Consolidated Statements of Cash Flows 5 Notes to Condensed Consolidated Financial Statements 6 Note 1. Basis of Presentation and Significant Accounting Policies 6 Note 2. Acquisitions and Divestitures 6 Note 3. Business Segments 9 Note 4. Revenue 11 Note 5. Earnings Per Common Share 14 Note 6. Balance Sheet Components 15 Note 7. Goodwill and Intangible Assets 15 Note 8. Borrowings 17 Note 9. Fair Value Measurements 17 Note 10. Restructuring Expenses and Asset Impairments 19 Note 11. Accumulated Other Comprehensive Income (Loss ) 20 Note 12. Share Repurchases 21 Note 13. Share-Based Compensation 21 Note 14. Retirement Benefits 26 Note 15. Commitments and Contingencies 27 Note 16. Income Taxes 27

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 28

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 41

Controls and Procedures

Item 4. Controls and Procedures 41

Other Information

Part II. Other Information

Legal Proceedings

Item 1. Legal Proceedings 42

Risk Factors

Item 1A. Risk Factors 42

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 42

Other Information

Item 5. Other Information 42

Exhibits

Item 6. Exhibits 43

Signatures

Signatures 44 Cautionary Statement Under the Private Securities Litigation Reform Act This quarterly report on Form 10-Q, including the "Overview," "Results of Operations" and "Liquidity and Capital Resources" sections of this Management's Discussion and Analysis of Financial Condition and Results of Operations, contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may relate to, among other things, the Company's business strategy, outlook and the assumptions underlying these expectations, capital return strategy, plant and equipment capacity for future growth, planned production, anticipated future acquisition behavior, resource and capital deployment, the Company's ability to adapt to macroeconomic challenges and anticipated adaptability of resource deployment, anticipated impacts of tariffs and global trade policies and changes in law, including the One, Big, Beautiful Bill Act, the Company's future market positioning, anticipated trends in end markets, including expectations regarding market sector contraction, recovery, stabilization or growth and underlying drivers of such expectations, expectations regarding future order volumes and order patterns, demand within end markets, availability and sufficiency of cash and financing alternatives, the impacts of any pending or threatened legal, regulatory and other proceedings involving the Company and its subsidiaries, anticipated benefits and restructuring charges. including severance charges, related to the Company's organizational changes, the anticipated tax treatment of the Company's recent acquisitions, the expected contingent consideration payable related to the Company's recent acquisitions, the anticipated benefits and performance of the Company's recent or future acquisitions, anticipated growth initiatives and expansions and the anticipated benefits of the Company's productivity and cost containment efforts, and a

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements IDEX CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF INCOME (In millions, except per share amounts) (unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Net sales $ 878.7 $ 798.2 $ 2,558.4 $ 2,405.9 Cost of sales 488.1 444.3 1,406.7 1,327.8 Gross profit 390.6 353.9 1,151.7 1,078.1 Selling, general and administrative expenses 204.7 182.9 617.7 560.8 Restructuring expenses and asset impairments 0.1 3.0 18.3 5.4 Operating income 185.8 168.0 515.7 511.9 Gain on sale of business — 0.6 — ( 4.0 ) Other (income) expense – net ( 1.2 ) 2.7 2.6 — Interest expense – net 16.5 10.3 48.2 27.8 Income before income taxes 170.5 154.4 464.9 488.1 Provision for income taxes 42.8 35.5 110.7 106.7 Net income 127.7 118.9 354.2 381.4 Net loss attributable to noncontrolling interest 0.1 0.2 0.7 0.4 Net income attributable to IDEX $ 127.8 $ 119.1 $ 354.9 $ 381.8 Earnings per common share: Basic earnings per common share attributable to IDEX $ 1.70 $ 1.57 $ 4.70 $ 5.03 Diluted earnings per common share attributable to IDEX $ 1.70 $ 1.57 $ 4.70 $ 5.02 Share data: Basic weighted average common shares outstanding 75.1 75.7 75.4 75.7 Diluted weighted average common shares outstanding 75.2 75.9 75.5 75.9 See Notes to Condensed Consolidated Financial Statements 1 Table of Contents IDEX CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (In millions) (unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Net income $ 127.7 $ 118.9 $ 354.2 $ 381.4 Other comprehensive (loss) income: Pension and other postretirement adjustments, net of tax ( 0.1 ) ( 0.1 ) ( 0.5 ) ( 0.4 ) Cumulative translation adjustment ( 2.8 ) 91.8 176.7 21.5 Other comprehensive (loss) income, net of tax ( 2.9 ) 91.7 176.2 21.1 Comprehensive income 124.8 210.6 530.4 402.5 Comprehensive loss attributable to noncontrolling interest 0.1 0.2 0.7 0.4 Comp

View Full Filing

View this 10-Q filing on SEC EDGAR